US equities |
SPCX $175.25 ▲+2.43% NVDA $242.22 ▲+1.39% MU $1,069.22 ▲+0.49% AMD $654.38 ▲+3.58% MRVL $290.62 ▲+7.14% SNDK $1,679.00 ▼-1.48% AVGO $377.22 ▲+4.06% TSLA $380.80 ▲+0.55%
FinancialContent

Latest News about Blood Disorders

Recent news which mentions Blood Disorders

Apellis - Sobi's Pegcetacoplan Wins European Approval For Rare Blood Disorder
Tickers APLS BIOVF
Tags General Benzinga Biotech
From Benzinga
EMA's CHMP Backs AstraZeneca's Drug For Rare Blood Disorder In Children
Tickers AZN AZNCF
Tags General AZN Biotech
From Benzinga
BioCryst Outlines Pivotal Trial Designs For BCX9930 In Rare Blood Disorder
Tickers BCRX
Tags Blood Disorders News Health Care
From Benzinga